|
|
|
Int'l Pharma & Device Compliance Congress XIII Features Annual CEE and MEA Compliance Update Roundtables
|
- Sponsored by ETHICS, the International Society of Healthcare Compliance Professionals
- Media Partners: Policy & Medicine Compliance Update and Rx Data News
- April 8 - 10, 2019
- Onsite at the Grand Hyatt Athens Athens, Greece
- www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com |
EARLY BIRD REGISTRATION
- SAVE UP TO €200 -
|
Register by March 15, 2019 and save up to €200.
Click here to register.
|
|
|
FEATURING ANNUAL CENTRAL & EASTERN EUROPE (CEE) COMPLIANCE BEST PRACTICES UPDATE BY
|
Martina Leposa
Healthcare Compliance Officer, Janssen-Cilag Ltd. (a Johnson & Johnson company); Chair, Compliance Committee, Association of Innovative Pharmaceutical Manufacturers, Budapest, Hungary |
Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie -- CIS, Limited, Moscow, Russian Federation |
Madina Plieva, PhD
Legal and Compliance Head, Russia, Bristol-Myers Squibb; Legal Director, Association of International Pharmaceutical Manufacturers (AIPM); Former Head of Legal Department, Kutafin Moscow State Law Academy, Moscow, Russian Federation
|
Evgeny Tilezhinsky, MBA, PhD
Law and Compliance Lead for Central and Eastern Europe, Bristol-Myers Squibb, Uxbridge, Middlesex, UK |
Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland (Moderator)
|
|
|
AND ANNUAL MIDDLE EAST AFRICA (MEA) COMPLIANCE BEST PRACTICES UPDATE BY
|
Maria Khoury, MBA, PharmD
Compliance Officer Levant, Roche; Chair, Lebanese Group of International Pharmaceutical Companies and Iraq LAWG (Local Area Working Group), Beirut, Lebanon |
Minal Patel
Health Care Compliance Officer, Pharma and Consumer, Johnson & Johnson, Johannesburg Area, South Africa
|
Rami A. Rajab
Chairman, Mecomed Medical Technology Association Middle East & Africa (MECOMED); Chairman, LIFE (LivaNova International Fellowship), International Corporate Social Responsibility; Former Vice President Market Access, Emerging Markets, LivaNova, Maidenhead, UK |
Laura Nassar, PharmD
Head of Compliance Middle East, Roche Pharmaceuticals; Chair, Compliance Committee, Pharmaceutical Research and Manufacturers Association, Gulf (PhRMAG); Former Regional Pharma HCC Officer Emerging Markets, Johnson & Johnson, Beirut, Lebanon (Moderator)
|
|
|
ATHENS, GREECE -- PHARMA UPDATE NEWS SERVICE™ -- FEBRUARY 21, 2019: The Thirteenth International Pharmaceutical and Medical Device Compliance Congress, www.InternationalPharmaCongress.com, will be held April 8 - 10, 2019 at the Grand Hyatt Athens in Athens, Greece.
|
|
KEYNOTE SPEAKERS
|
Gérald Begranger
Head of Department, Deputy Director, French Anti-Corruption Agency (APA), Paris, France |
Julie Bonhomme
EFPIA Legal & Compliance Director, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium |
Rachel Cooper, LLB, MSc
Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, Former Head, Government Relations, World Vision UK, Former Vice Consul, British Embassy, Copenhagen, Deputy Head of Mission, British Embassy, Bratislava, Deputy High Commissioner, Freetown, London, UK
|
Holger Diener
Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry ("FSA"), Member, Ethics and Compliance Committee and Vice Chair, Code Committee, EFPIA, Member, IFPMA Code Compliance Network, Berlin, Germany |
Robert I. Dodge, JD
Assistant Director, FCPA Unit, US Securities & Exchange Commission, Former Assistant U.S. Attorney, US Attorney's Office, Western District of Michigan, Former Assistant Section Chief, Environmental Defense Section, US Department of Justice, Washington, DC, USA |
Abhiroop Gandhi
Trust and Compliance Officer, Verily Life Sciences (an Alphabet company), Former Vice President, Corporate Compliance, Mallinckrodt, San Francisco, CA, USA
|
José F. Zamarriego Izquierdo, MBA, PhD
Director, Code of Practice Surveillance Unit, Farmaindustria, Chair, EFPIA's Code Committee, Coordinator, EFPIA e4ethics Initiative, Chairman, IFPMA's Code Complaint Procedure Appeal Group, Madrid, Spain |
Sofie Melis
Head of Ethics and Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland |
Guido Palazzo, PhD
Professor of Business Ethics, Department of Strategy, Globalization and Society, University of Lausanne, Lausanne, Switzerland
|
Piergiorgio Pepe, MA EU Law
President, Quantum Ethics, Ethics and Compliance Lecturer, SciencesPo, Former Compliance Director Western Europe & Canada, AbbVie, Former Director, Compliance & Ethics EMEA, Bristol-Myers Squibb, Paris, France |
Rami A. Rajab
Chairman, Mecomed Medical Technology, Association Middle East & Africa (MECOMED), Chairman, LIFE (LivaNova International Fellowship), International Corporate Social Responsibility, Former VP Market Access, Emerging Markets, LivaNova, Maidenhead, UK |
Harout Semerjian, MBA
Executive Vice-President & Chief Commercial Officer, Ipsen, Former Senior Vice President and Global Launch Lead, Ribociclib, Novartis Oncology, New York, NY, USA
|
Heather Simmonds
Director, Prescription Medicines Code of Practice Authority, London, United Kingdom |
Christopher L. White, JD
Chief Operating Officer & General Counsel, Advanced Medical Technology Association (AdvaMed), Washington, DC, USA
|
|
|
|
FEATURING PRECONFERENCE SESSIONS
|
- Precon I: A Workshop on Practical Case Studies & Exercises in Ethics & Compliance
- Precon II: Advanced Investigations
|
|
PLENARY SESSIONS
|
- International Pharma Congress Vision and Overview
- Keynote Address: Pharma Executive
- Compliance Issues Raised by Pharma & Device New Business Models
- Global Compliance Codes Update
- Annual Chief Compliance Officer Roundtable
- Keynote Address: Transparency International
- Annual Anticorruption Roundtable
- Update on the new French Sapin II Law
- Annual FCPA Update Roundtable
- Multi-jurisdictional Anticorruption Investigations & Prosecutions
- Ethics and Compliance Keynote Address
- The Emerging Role of Technology Companies in Life Science
- IFPMA Global Compliance Updates
- Transforming Compliance into a Profession
|
|
|
|
AND CONCURRENT MINI SUMMITS
|
- Annual Medical Device Ethics & Compliance Roundtable
- Digitalization of Compliance
- Data Privacy, Consent Management and GDPR Update
- Ethics & Compliance Issues in Patient Relationships
- Annual Central and Eastern Europe (CEE) Compliance Update
- Annual Middle East Africa (MEA) Compliance Update
- EU & US Whistleblower Updates
- Using Risk Assessment to Design Compliance Programs
- Analytics with Reference to Transparency & Monitoring
- Improving the Future of Compliant HCP Engagements
- Reducing FCPA Exposure through Better Use of Data
- Compliance Issues in Manufacturer Relationships with Foundations
- Behavioral Science to Enhance Effectiveness of Compliance Programs
- Third Party Due Diligence and Management
- Structuring an Efficient Digital Compliance Framework
- Auditing and Monitoring Workgroup
- R&D and Clinical Trials Compliance Workgroup
- Working with in-company Business Partners Workgroup
|
|
|
FEATURED FACULTY
|
Pablo Rojas Abad, LLM
Manager, Legal and Compliance, MedTech Europe, Brussels, Belgium |
David Andersen
Partner, Pharmaceuticals and Life Sciences, PwC, London, UK |
Yogesh Bahl, CPA, MBA
Managing Director, Alix Partners, New York, NY
|
Michael Bartke, PhD
Director Ethics & Compliance, Alexion, Former Director Compliance Management, Daiichi Sankyo Europe GmbH, Strategic Committee, ETHICS, Munich, Germany |
Ann Beasley, JD
Director, Life Sciences Regulatory & Compliance, Navigant; Former Senior VP, CCO, Biogen, Boston, MA, USA |
Enno Behrendt
Compliance Officer, Siemens Healthcare GmbH, General Legal Counsel, evosoft GmbH, Erlangen, Germany
|
Thomas W. Beimers, JD
Partner, Hogan Lovells; Former Senior Counsel for Administrative and Civil Remedies, Office of the Inspector General, Department of Health and Human Services; Minneapolis, MN, USA |
Maike Bermüller
Senior Legal Counsel and Global Healthcare Compliance Officer, Boehringer Ingelheim, Frankfurt Am Main, Germany |
Chris van Bronckhorst
Global Compliance Director, IQVIA, The Hague, Netherlands
|
Ryan Burger, MS
Head, Global Assurance & Reporting Services, Astra Zeneca, Former Manager, Aggregate Spend and Transparency Reporting, Daiichi Sankyo, Former Manager, Transparency Operations, Sanofi, Former Manager, Disclosure Reporting, Pfizer, New York, NY |
Keith Burn
Global Investigations Director, Ipsen, Former Associate Investigator, Parliamentary and Health Service Ombudsman, NHS, Former Detective Constable, London Metropolitan Police, Amersham, Buckinghamshire, UK |
Antonio Cavallaro
Compliance Officer Merck Serono Italy, Former Head of Compliance Takeda Italy, Rome, Italy
|
Matthew Coombs
Director, Account & Services Offering Management, Commercial Compliance, IQVIA, Former Strategic Business Director, Qforma, London, UK |
Peter Dieners, Esq.
Partner and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Co-chair, Legal Affairs Focus Group (LA FG), EUCOMED, Co-chair, Compliance Network (CN), EUCOMED, Düsseldorf, Germany |
Julien Durand, MBA, PhD
Executive Director Compliance & Ethics, Amgen, Former Chief Privacy Officer and Global Technology Compliance Head, AstraZeneca, Zürich, Switzerland
|
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK |
Karen Eryou
Head, Ethics & Compliance Programs, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium |
George Fife
Partner, Fraud Investigation & Dispute Services, EY, Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France
|
Monique Fonfara-Weinberg
Compliance Manager, Boehringer Ingelheim Corporate Center GmbH, Ingelheim am Rhein, Germany |
Carlo Geninazza
Senior Manager, CAWECO GmbH, Munich, Germany |
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA
|
Riccardo Giannetti
Scheme Manager, Inveo, Roma, Italy |
Betania Glorio
Global Compliance Officer Healthcare, Merck KGaA, Former Senior Director, Legal and Compliance EMEA, Horizon, Former Senior Counsel, Regional Compliance Director, EUCAN, Pfizer, Darmstadt, Germany |
Cecile Gousset
Head of Compliance Risk Assessment, Policies & Education, Global Ethics & Business Integrity, Sanofi, Paris, France
|
Tom Gregory, MBA
Partner, Forensic & Integrity Services, EY, Atlanta, USA |
Ulf H. Grundmann
Partner, FDA and Life Sciences, King & Spalding LLP, Frankfurt am Main, Germany |
Glen Haith, JD
Global Head, Integrity & Compliance Pharma Medical Affairs, Novartis Pharmaceuticals, Former Associate Vice President and Chief Compliance Officer, ImClone Systems, Basel, Switzerland
|
Thomas K. Hauser, MA HSG, MSJ
Director, Life Sciences Governance, Risk Management and Compliance Practice, Navigant; Treasurer, ETHICS; Former Global CCO, Siemens Healthcare, London, UK |
Gérald Hucky
Head Group Compliance, Sonova Group, Former Compliance Audit Manager, NameZimmer Biomet, Zürich, Switzerland |
Brett Hudson, MBIM
Head of Group I&C Group Integrity & Compliance, Novartis, Former Global Program Director - Integrity & Compliance, Sandoz, Basel, Switzerland
|
Arielle Hung
Compliance Counsel, Merck KGaA, Darmstadt, Germany |
Franziska Janorschke
Global Head Business Practices Office, Novartis International AG, Basel, Switzerland |
Carl Judge
Partner, Forensic & Integrity Services, EY, London, UK
|
Daniel T. Kessler, MA, JD
Founder & Principal, Givon Advisors; Former Chief Counsel, Int'l Trade Controls, Pfizer; Tel Aviv, Israel |
Timur Khasanov-Batirov, LLM
Compliance Officer, Russia, CIS & Romania, Dr. Reddy's Laboratories, Author, Compliance Man of Integrity Corp. and Integrity Corp. 50 Tips for Your Compliance, Program in the Post-Soviet States, Moscow, Russian Federation |
Maria Khoury, MBA, PharmD
Compliance Officer Levant, Roche, Chair, Lebanese Group of International Pharmaceutical Companies and Iraq LAWG (Local Area Working Group), Beirut, Lebanon
|
Anita Kyung-Hee Kim-Reinartz
Partner, Forensic & Integrity Services, EY, Düsseldorf, Germany |
Irith Kist, LLM, CIP/M
Functionaris Gegevensbescherming/ Data Protection Officer, The Netherlands Cancer Institute, Amsterdam, The Netherlands |
Katharina Kneisel, MBA
Senior Manager Corporate Compliance, Fresenius SE & Co. KGaA, Bad Homburg vor der Höhe, Hessen, Germany
|
Tomasz Kruk
Head of Compliance, Vifor Pharma, Switzerland |
Julie Kudyba
Head International Ethics & Compliance, Shire, Former Global Head Integrity & Compliance, Alcon, Former Global Privacy Officer, Novartis Pharma AG, Fort Worth, TX, USA |
Chrystel Lanxade
Regional Compliance Officer, Europe Middle East Africa, Alcon; Former Head of Legal & Compliance Alcon France, Legal & Compliance Head Novartis Consumer Health France, Legal Counsel, Leem; Lawyer at the Paris bar, DEA, DESS; Cointrin, Canton of Geneva, Switzerland
|
Aline Lautenberg
General Counsel and Director Legal & Compliance, MedTech Europe, Brussels, Belgium |
Edoardo Lazzarini, PhD
Healthcare Compliance Consultant, Former EuCan Ethics & Compliance Initiatives Director, Takeda Pharmaceuticals, Former Compliance Officer EMEA (Europe, Middle East & Africa), Zimmer Biomet, Milan, Italy |
Martina Leposa
HealthCare Compliance Officer, Janssen-Cilag Ltd. (a Johnson & Johnson company), Chair, Compliance Committee, Association of Innovative Pharmaceutical Manufacturers, Budapest, Hungary
|
Carlos Romero Lopez, LLB, MA
Head of Compliance Healthcare South Europe, Merck Group, Madrid, Spain |
Michael K. Loucks, JD
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, US Department of Justice, Washington, DC, USA |
Paul J. Melling, JD
Founding Partner, Baker & McKenzie -- CIS, Limited, Moscow, Russia
|
Laetitia Ducroquet Minel
Director, Ethics & Compliance, Ipsen, Boulogne-Billancourt, France |
Laura Nassar, PharmD
Head of Compliance Middle East, Roche Pharmaceuticals, Chair, Compliance Committee, Pharmaceutical Research, and Manufacturers Association, Gulf (PhRMAG), Beirut, Lebanon |
Michael O'Connor, MS
Vice President of Compliance Technology, Porzio Life Sciences, LLC, Former Global Head Compliance and Ethics Operations, Alexion, Former Executive Director, Global Head, IS Business Consulting, Boehringer Ingelheim, New York, NY
|
Nicola Orlandi
Head, Data Privacy Pharma, Global Privacy Office, Novartis International AG; Former Head of Legal and Compliance, Sandoz S.p.A., Basel, Switzerland |
Minal Patel
Health Care Compliance Officer, Pharma and Consumer, Johnson & Johnson, Johannesburg Area, South Africa |
Marie-Claire Pickaert
Former Deputy Director General, Chief Financial Officer and Ambassador to the Medical Communities, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium
|
Madina Plieva, PhD
Legal and Compliance Head, Russia, Bristol-Myers Squibb, Former Legal Director, Association of International Pharmaceutical Manufacturers (AIPM), Former Head of Legal Department, Kutafin Moscow State Law Academy, Moscow, Russia |
Mario Prohasky
Global Compliance Consultant, IQVIA, London, UK |
Ariadna Quesada, MSJ
Law, Ethics and Compliance Officer, The Netherlands, AbbVie; Former Compliance Manager International, MicroPort Orthopedics Inc., Amsterdam, Netherlands
|
Giuseppe Saporito, LLM
Global Legal & Regulatory Expert, IQVIA, Milan, Italy |
Antje Petersen Schmalnauer, JD, LLM
Group General Counsel, Sonova Group, Former Interim VP Legal and General Counsel, Kautex Textron, Former Global Privacy and Data Protection Officer, Biomet, Cologne, Germany |
Leonardo Silva, LLM
Global Compliance Officer, Head of Global Compliance, Ferring, Former Head of Compliance, Acino Group, Former Compliance Director, Emerging Markets, Takeda, St. Prex, Switzerland
|
Ruth Sturm
Head of Compliance EMEA, SIEMENS Healthineers, Erlangen, Germany |
Kathy Tench, MS
Director, Life Sciences Compliance, KPMG Switzerland, Former Senior Director of Compliance, Optimer Pharmaceuticals, Zürich, Switzerland |
Evgeny Tilezhinsky, MBA, PhD
Law and Compliance Lead for the Central and Eastern Europe, Bristol-Myers Squibb, Uxbridge, Middlesex, UK
|
Eirini Tsotra, MS, CIPP/E, CIPM, CISA
Director, Privacy & Data Protection, Ferring International Centre SA, St-Prex, Switzerland |
Tamara Tubin
International Compliance Director, Corporate Compliance, Wright Medical Group N.V., Vice Chair, Ethics & Compliance Committee, MedTech Europe, Member, Strategic Committee, ETHICS, Zürich, Switzerland |
Satnam Tumani, LLB
Partner, Kirkland & Ellis International LLC, Former Head of Bribery & Corruption, Serious Fraud Office, London, UK
|
Katharina Weghmann, MBA, EdD
Associate Partner, Forensic & Integrity Services, EY, Düsseldorf, Germany |
Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland
|
Niels Wohlwend, Master of Law (lic iur), MAES
Senior Director Healthcare Compliance (HCC) Europe & Canada, Celgene, Member, WFPIA Ethics & Compliance Committee, Former Global Head of Compliance, ACINO, Former Head of Compliance APAC, LATAM and MEA, Mundipharma, Boudry, Canton of Neuchâtel, Switzerland |
Elisabethann Wright, LLB
Partner, Hogan Lovells, Former, Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium
|
|
|
|
2019 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
THIRTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL
DEVICE COMPLIANCE CONGRESS
|
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partners: Policy & Medicine Compliance Update and Rx Data News
April 8 - 10, 2019
Grand Hyatt Athens
Athens, Greece
www.International PharmaCongress.com
|
|
NINTH ASIA PACIFIC
PHARMACEUTICAL AND MEDICAL
DEVICE COMPLIANCE CONGRESS
|
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partners: Policy & Medicine Compliance Update
September, 2019
Shanghai, China
www.Asian PharmaCongress.com
|
|
TWENTIETH ANNUAL PHARMACEUTICAL AND
MEDICAL DEVICE COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs, Policy & Medicine Compliance Update and Rx Data News
November 6 - 8, 2019
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
|
|
|
|
|
|
SPONSORED BY:
|
|
|
CO CHAIRS
|
Dante Beccaria
Senior Vice President, Global Compliance Officer, Head of Ethics & Business Integrity Department, Sanofi, Paris, France
Stephen Nguyen Duc
Global Head of Ethics & Compliance, Medday Pharmaceuticals, Board Member, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Rungis, France
Suzanne Durdevic, LLM
Former Senior Director, General Counsel Europe, Boston Scientific International, Member, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Paris, France
Dominique Laymand, Esq.
Executive Vice President, Chief Ethics and Compliance Officer and CSR, Ipsen; Honorary President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France
Roeland Van Aelst
Regional Vice President -- HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Chairman, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium
|
|
GRANTORS
|
|
DIAMOND
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
MEDIA PARTNER:
|
|
|
CONTINUING EDUCATION CREDITS:
|
Accounting Professionals: Approved for up to 18.5 NASBA CPE credits.
Attorneys: Approved for up to 14.00 Pennsylvania CLE Credits.
Compliance Professionals: This education activity has been submitted to the Compliance Certification Board (CCB)® and is currently pending their review for approval of CCB CEUs.
Click here for more information.
|
|
STAY CONNECTED
|
Tweet using #PharmaCongress
|
|
THE CONGRESS IS
|
|
|
PAST GLOBAL PHARMA COMPLIANCE CONGRESSES
|
2007 - Brussels
2008 - Paris
2009 - Rome
2010 - Berlin
2011 - Istanbul
2011 - Singapore
2012 - Budapest
2012 - Shanghai
2012 - São Paulo
2013 - Madrid
2013 - Kuala Lumpur
2014 - Dubai
2014 - Mexico City
2014 - Shanghai
2015 - Manila
2016 - Warsaw
2017 - Lisbon
2018 - Vienna
|
|
ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
|
|
|
|
|
|
